JULY NEWSLETTERIn This Issue Integral BioSystems in the News...

First Page		Document Content
Date: 2014-03-13 17:27:16 Pharmaceuticals policy Pharmacy Patent law Drug repositioning Generic drug Drug discovery Abbreviated New Drug Application Patentability Drug delivery Pharmaceutical sciences Pharmacology Pharmaceutical industry		JULY NEWSLETTERIn This Issue Integral BioSystems in the News... Add to Reading List Source URL: www.integralbiosystems.com Download Document from Source Website File Size: 51,34 KB Share Document on Facebook

	Page 1 of 12 Isaac Madan March 14, 2014 BMI 258, Final project The potential of genome-based computational methods for drug repositioning Drug discovery and development are critical components in today’s healthcare DocID: 1uC3m - View Document
	CDKL5 Program of Excellence Pilot Grant Program Application Title: Exploiting computational biology for target identification and drug repositioning in CDKL5 disorder PI: Nicoletta Landsberger, PhD Institution: Universit DocID: 1uh0D - View Document
	Josephine Chen December 2, 2014 Computational Drug Repositioning Introduction As a high school senior doing research at Stanford Medical School as part of the SIMR program, I remember listening to a seminar talk given by DocID: 1tOrG - View Document
	Computational drug repositioning based on side-effects mined from social media Timothy Nugent, Vassilis Plachouras and Jochen L. Leidner Thomson Reuters, Corporate Research and Development, London, United Kingdom ABSTRA DocID: 1oN3v - View Document
	IFOM: A YEAR IN REVIEWDrug repositioning A rapid and economic alternative to DocID: 1o113 - View Document